Scientific inquiry into marijuana received a big boost this week, courtesy of a new partnership between American and Czech stakeholders.
A coalition of activists, politicians, scientists and businesses announced the establishment of a new research center, the International Cannabis and Cannabinoid Institute (ICCI), which will be based in the Czech Republic. And what the center produces could have major benefits for medical cannabis businesses all over the globe.
“The main work of the ICCI is to provide scientific instruments to public and private institutions all over the world,” CEO Pavel Kubu said in a statement.
Backers of the ICCI include Americans for Safe Access, the Czech patient advocacy group KOPAC, the New York-based cannabis investment firm Dioscorides Global Holdings, and multiple universities and high-tech companies.
The Czech Republic’s Health Minister, Svatopluk Nemecek, joined the group for a public announcement, which provided the institute with a defacto stamp of approval from the government.
Medical marijuana has been legal in the Czech Republic since 2013.
